Clinical trial
A Prospective, Blinded, Cross-Over Trial of the Exposure-Response Relationship of Terbutaline Sulfate in Adults With Asthma
NCT04973345 is registered in ClinicalTrials.gov with Kanecia Obie Zimmerman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Blinded, Cross-Over Trial of the Exposure-Response Relationship of Terbutaline Sulfate in Adults With Asthma
- Lead sponsor
- Kanecia Obie Zimmerman
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- July 7, 2023
- Completion date
- December 31, 2026
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.